Anti-GALNTL5 monoclonal antibody

Pre-made anti-GALNTL5 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GALNTL5/GALNTL5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0888-Ab-1/ GM-Tg-hg-IP0888-Ab-2Anti-Human GALNTL5 monoclonal antibodyHuman
GM-Tg-rg-IP0888-Ab-1/ GM-Tg-rg-IP0888-Ab-2Anti-Rat GALNTL5 monoclonal antibodyRat
GM-Tg-mg-IP0888-Ab-1/ GM-Tg-mg-IP0888-Ab-2Anti-Mouse GALNTL5 monoclonal antibodyMouse
GM-Tg-cynog-IP0888-Ab-1/ GM-Tg-cynog-IP0888-Ab-2Anti-Cynomolgus/ Rhesus macaque GALNTL5 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0888-Ab-1/ GM-Tg-felg-IP0888-Ab-2Anti-Feline GALNTL5 monoclonal antibodyFeline
GM-Tg-cang-IP0888-Ab-1/ GM-Tg-cang-IP0888-Ab-2Anti-Canine GALNTL5 monoclonal antibodyCanine
GM-Tg-bovg-IP0888-Ab-1/ GM-Tg-bovg-IP0888-Ab-2Anti-Bovine GALNTL5 monoclonal antibodyBovine
GM-Tg-equg-IP0888-Ab-1/ GM-Tg-equg-IP0888-Ab-2Anti-Equine GALNTL5 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0888-Ab-1/ GM-Tg-hg-IP0888-Ab-2; GM-Tg-rg-IP0888-Ab-1/ GM-Tg-rg-IP0888-Ab-2;
GM-Tg-mg-IP0888-Ab-1/ GM-Tg-mg-IP0888-Ab-2; GM-Tg-cynog-IP0888-Ab-1/ GM-Tg-cynog-IP0888-Ab-2;
GM-Tg-felg-IP0888-Ab-1/ GM-Tg-felg-IP0888-Ab-2; GM-Tg-cang-IP0888-Ab-1/ GM-Tg-cang-IP0888-Ab-2;
GM-Tg-bovg-IP0888-Ab-1/ GM-Tg-bovg-IP0888-Ab-2; GM-Tg-equg-IP0888-Ab-1/ GM-Tg-equg-IP0888-Ab-2
Products NameAnti-GALNTL5 monoclonal antibody
Formatmab
Target NameGALNTL5
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GALNTL5 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0888-Ag-1Recombinant multi-species GLTL5/ GALNTL5/ GALNACT19 protein


    Target information

    Target IDGM-IP0888
    Target NameGALNTL5
    Gene ID168391,67909,499968,716567,611040,101086384,617031,100064586
    Gene Symbol and Synonyms1700021B12Rik,GalNAc-T5L,GALNACT19,GALNT15,GALNTL5
    Uniprot AccessionQ7Z4T8
    Uniprot Entry NameGLTL5_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000106648
    Target ClassificationN/A

    The target: GALNTL5, gene name: GALNTL5, also named as GALNACT19, GALNT15, GalNAc-T5L. Predicted to enable metal ion binding activity and transferase activity. Involved in spermatid development. Predicted to be located in late endosome membrane. Predicted to be integral component of membrane. Predicted to be active in Golgi apparatus. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.